Global Chronic Migraine Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: GB40C0214D05EN
QYResearch

Abstracts

This report focuses on the global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Migraine Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Novartis
• Pfizer
• AstraZeneca
• Allergan
• GlaxoSmithKline
• Eli Lilly
• Merck
• Johnson&Johnson
• Zosano
• Alder BioPharmaceuticals

Market segment by Type, the product can be split into

• Drug Treatment
• Substitution Treatment

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Chronic Migraine Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Chronic Migraine Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Migraine Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Migraine Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Chronic Migraine Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Substitution Treatment
1.5 Market by Application
  1.5.1 Global Chronic Migraine Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Migraine Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Chronic Migraine Treatment Industry
    1.6.1.1 Chronic Migraine Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Chronic Migraine Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Chronic Migraine Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Chronic Migraine Treatment Market Perspective (2015-2026)
2.2 Chronic Migraine Treatment Growth Trends by Regions
  2.2.1 Chronic Migraine Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Chronic Migraine Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Chronic Migraine Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Chronic Migraine Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Chronic Migraine Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Chronic Migraine Treatment Players by Market Size
  3.1.1 Global Top Chronic Migraine Treatment Players by Revenue (2015-2020)
  3.1.2 Global Chronic Migraine Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Chronic Migraine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Migraine Treatment Market Concentration Ratio
  3.2.1 Global Chronic Migraine Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Chronic Migraine Treatment Revenue in 2019
3.3 Chronic Migraine Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Migraine Treatment Product Solution and Service
3.5 Date of Enter into Chronic Migraine Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Chronic Migraine Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Migraine Treatment Forecasted Market Size by Type (2021-2026)

5 CHRONIC MIGRAINE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Chronic Migraine Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Migraine Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Chronic Migraine Treatment Market Size (2015-2020)
6.2 Chronic Migraine Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Migraine Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Migraine Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Chronic Migraine Treatment Market Size (2015-2020)
7.2 Chronic Migraine Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Migraine Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Migraine Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Chronic Migraine Treatment Market Size (2015-2020)
8.2 Chronic Migraine Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Chronic Migraine Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Chronic Migraine Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Novartis
  9.1.1 Novartis Company Details
  9.1.2 Novartis Business Overview and Its Total Revenue
  9.1.3 Novartis Chronic Migraine Treatment Introduction
  9.1.4 Novartis Revenue in Chronic Migraine Treatment Business (2015-2020))
  9.1.5 Novartis Recent Development
9.2 Pfizer
  9.2.1 Pfizer Company Details
  9.2.2 Pfizer Business Overview and Its Total Revenue
  9.2.3 Pfizer Chronic Migraine Treatment Introduction
  9.2.4 Pfizer Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.2.5 Pfizer Recent Development
9.3 AstraZeneca
  9.3.1 AstraZeneca Company Details
  9.3.2 AstraZeneca Business Overview and Its Total Revenue
  9.3.3 AstraZeneca Chronic Migraine Treatment Introduction
  9.3.4 AstraZeneca Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.3.5 AstraZeneca Recent Development
9.4 Allergan
  9.4.1 Allergan Company Details
  9.4.2 Allergan Business Overview and Its Total Revenue
  9.4.3 Allergan Chronic Migraine Treatment Introduction
  9.4.4 Allergan Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.4.5 Allergan Recent Development
9.5 GlaxoSmithKline
  9.5.1 GlaxoSmithKline Company Details
  9.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.5.3 GlaxoSmithKline Chronic Migraine Treatment Introduction
  9.5.4 GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.5.5 GlaxoSmithKline Recent Development
9.6 Eli Lilly
  9.6.1 Eli Lilly Company Details
  9.6.2 Eli Lilly Business Overview and Its Total Revenue
  9.6.3 Eli Lilly Chronic Migraine Treatment Introduction
  9.6.4 Eli Lilly Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.6.5 Eli Lilly Recent Development
9.7 Merck
  9.7.1 Merck Company Details
  9.7.2 Merck Business Overview and Its Total Revenue
  9.7.3 Merck Chronic Migraine Treatment Introduction
  9.7.4 Merck Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.7.5 Merck Recent Development
9.8 Johnson&Johnson
  9.8.1 Johnson&Johnson Company Details
  9.8.2 Johnson&Johnson Business Overview and Its Total Revenue
  9.8.3 Johnson&Johnson Chronic Migraine Treatment Introduction
  9.8.4 Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.8.5 Johnson&Johnson Recent Development
9.9 Zosano
  9.9.1 Zosano Company Details
  9.9.2 Zosano Business Overview and Its Total Revenue
  9.9.3 Zosano Chronic Migraine Treatment Introduction
  9.9.4 Zosano Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.9.5 Zosano Recent Development
9.10 Alder BioPharmaceuticals
  9.10.1 Alder BioPharmaceuticals Company Details
  9.10.2 Alder BioPharmaceuticals Business Overview and Its Total Revenue
  9.10.3 Alder BioPharmaceuticals Chronic Migraine Treatment Introduction
  9.10.4 Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2015-2020)
  9.10.5 Alder BioPharmaceuticals Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Chronic Migraine Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Migraine Treatment Revenue
Table 3. Ranking of Global Top Chronic Migraine Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Migraine Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Substitution Treatment
Table 7. COVID-19 Impact Global Market: (Four Chronic Migraine Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Chronic Migraine Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Chronic Migraine Treatment Players to Combat Covid-19 Impact
Table 12. Global Chronic Migraine Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Chronic Migraine Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Chronic Migraine Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Chronic Migraine Treatment Market Share by Regions (2015-2020)
Table 16. Global Chronic Migraine Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Chronic Migraine Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Chronic Migraine Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Chronic Migraine Treatment Players
Table 23. Global Chronic Migraine Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Chronic Migraine Treatment Market Share by Players (2015-2020)
Table 25. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2019)
Table 26. Global Chronic Migraine Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Chronic Migraine Treatment Product Solution and Service
Table 29. Date of Enter into Chronic Migraine Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Chronic Migraine Treatment Market Size Share by Type (2015-2020)
Table 33. Global Chronic Migraine Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Chronic Migraine Treatment Market Size Share by Application (2015-2020)
Table 35. Global Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Chronic Migraine Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Chronic Migraine Treatment Market Share (2019-2020)
Table 39. North America Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Chronic Migraine Treatment Market Share by Type (2015-2020)
Table 41. North America Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Chronic Migraine Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Chronic Migraine Treatment Market Share (2019-2020)
Table 45. Europe Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Chronic Migraine Treatment Market Share by Type (2015-2020)
Table 47. Europe Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Chronic Migraine Treatment Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Chronic Migraine Treatment Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Chronic Migraine Treatment Market Share (2019-2020)
Table 51. Asia-Pacific Chronic Migraine Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Chronic Migraine Treatment Market Share by Type (2015-2020)
Table 53. Asia-Pacific Chronic Migraine Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Chronic Migraine Treatment Market Share by Application (2015-2020)
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Product
Table 58. Novartis Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 59. Novartis Recent Development
Table 60. Pfizer Company Details
Table 61. Pfizer Business Overview
Table 62. Pfizer Product
Table 63. Pfizer Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 64. Pfizer Recent Development
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Product
Table 68. AstraZeneca Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 69. AstraZeneca Recent Development
Table 70. Allergan Company Details
Table 71. Allergan Business Overview
Table 72. Allergan Product
Table 73. Allergan Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 74. Allergan Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Product
Table 83. Eli Lilly Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 84. Eli Lilly Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Johnson&Johnson Business Overview
Table 91. Johnson&Johnson Product
Table 92. Johnson&Johnson Company Details
Table 93. Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 94. Johnson&Johnson Recent Development
Table 95. Zosano Company Details
Table 96. Zosano Business Overview
Table 97. Zosano Product
Table 98. Zosano Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 99. Zosano Recent Development
Table 100. Alder BioPharmaceuticals Company Details
Table 101. Alder BioPharmaceuticals Business Overview
Table 102. Alder BioPharmaceuticals Product
Table 103. Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2015-2020) (Million US$)
Table 104. Alder BioPharmaceuticals Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Chronic Migraine Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Substitution Treatment Features
Figure 4. Global Chronic Migraine Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Chronic Migraine Treatment Report Years Considered
Figure 9. Global Chronic Migraine Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Chronic Migraine Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Chronic Migraine Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Chronic Migraine Treatment Market Share by Players in 2019
Figure 14. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Chronic Migraine Treatment Revenue in 2019
Figure 16. North America Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Chronic Migraine Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Novartis Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 21. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Pfizer Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 29. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Eli Lilly Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 33. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Johnson&Johnson Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 35. Zosano Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Zosano Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 37. Alder BioPharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Alder BioPharmaceuticals Revenue Growth Rate in Chronic Migraine Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed